Hypothalamic-pituitary-adrenal axis response in borderline personality disorder without post-traumatic features

British Journal of Psychiatry

Volumn 190, Issue APR., 2007, Pages 357-358

  Carrasco, Jose L ^a,b   Díaz Marsá, Marina ^a   Pastrana, Jose I ^a   Molina, Rosa ^a   Brotons, Loreto ^a   López Ibor, María I ^a   López Ibor, Juan J ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; ARTICLE; BORDERLINE STATE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; POSTTRAUMATIC STRESS DISORDER;

ADULT; ANALYSIS OF VARIANCE; BORDERLINE PERSONALITY DISORDER; DEXAMETHASONE; FEEDBACK, BIOCHEMICAL; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE;

EID: 34147223920     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.bp.106.022590     Document Type: Article

References (11)

1. Bernstein, D. P., Stein, J. A., Newcomb, M. D., et al (2003) Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse and Neglect, 27, 169-190.
2. Carrasco, J. L., Díaz-Marsá, M., Pastrana, J., et al (2003) Enhanced suppression of cortisol after dexamethasone test in borderline personality disorder. A pilot study. Actas Espanolas de Psiquiatria, 31; 138-141.
3. First, M. B., Spitzer, R. L., Gibbon, M., et al (1995) Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). New York State Psychiatric Institute.
4. First, M. B., Gibbon, M., Spitzer, R. L., et al (1997) Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). American Psychiatric Press.
5. Grossman, R., Yehuda, R., New, A., et al (2003) Dexamethasone suppression test findings in subjects with personality disorders: associations with posttraumatic stress disorder and major depression. American Journal of Psychiatry, 160, 1291-1297.
6. Lange, W., Wulff, H., Berea, C., et al (2005) Dexamethasone suppression test in borderline personality disorder - effects of posttraumatic stress disorder. Psychoneuroendocrinology, 30, 919-923.
7. Lieb, K., Rexhausen, J. E., Kahl, K. G., et al (2004) Increased diurnal salivary cortisol in women with borderline personality disorder. Journal of Psychiatric Research, 38, 559-565.
8. Rinne, T., de Kloet, E. R., Wouters, L., et al (2002) Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/ corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biological Psychiatry, 52, 1102-1112.
9. Sternbach, H. A., Fleming, J., Extein, I., et al (1983) The dexamethasone suppression and thyrotropin-releasing-hormone tests in depressed borderline patients. Psychoneuroendocrinology, 8, 459-462.
10. Yehuda, R., Halligan, S. L., Golier, J. A., et al (2004) Effects of trauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder. Psychoneuroendocrinology, 29, 389-404.
11. Zanarini, M. C., Vujanovic, A. A., Parachini, E. A., et al (2003) Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. Journal of Personality Disorders, 17, 233-242.